INVO Fertility Inc
IVF
4 hedge funds and large institutions have $1.54M invested in INVO Fertility Inc in 2023 Q1 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, 1 reducing their positions, and closing their positions.
387% more capital inflows, than outflows
Capital inflows: $824K | Capital outflows: $169K
33% more funds holding
Funds holding: 3 → 4 (+1)
6.48% more ownership
Funds ownership: 10.79% → 17.28% (+6.5%)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Armistice Capital
New York
|
+$824K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
-$137K |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$21.2K |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$10.3K |
| 4 |
Beacon Capital Management LLC (Tennessee)
Franklin,
Tennessee
|
-$259 |
IVF Hedge Fund Activity: Q1 2023 in Review
4 of the 6,289 institutional investors tracked by Wall St. Rank reported a position in INVO Fertility Inc (IVF) for Q1 2023, worth a combined $1.54M — up 173% from $564K a quarter earlier.
Buyers outnumbered sellers: 1 fund opened new IVF positions and 0 closed out — a net gain of 1 holder — while 0 added to existing stakes and 1 trimmed.
The largest buyer was Armistice Capital, opening a new position worth an estimated $824K. The largest seller was Vanguard Group, cutting an estimated $137K.
- 4 institutional investors held INVO Fertility Inc (IVF) as of Q1 2023, up from 3 in Q4 2022.
- Funds reported $1.54M of INVO Fertility Inc stock for Q1 2023, up 173% quarter-over-quarter.
- 1 fund opened new INVO Fertility Inc positions in Q1 2023 and 0 closed out, a net change of +1 holder.
- The largest INVO Fertility Inc buyer in Q1 2023 was Armistice Capital, an estimated $824K added.
- The largest INVO Fertility Inc seller in Q1 2023 was Vanguard Group, an estimated $137K sold.
Based on aggregated 13F filings for Q1 2023.